Risk of pneumonia and other complications of influenza-like illness in patients treated with oseltamivir

Abstract

The risk of pneumonia, antibiotic dispensing, and hospitalization was reduced in patients with ILI who received oseltamivir compared to no antiviral therapy. These findings were based on health care claims only and have not been verified through medical record review.